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Evaluation of NHS Direct ‘‘referral’’ to community
pharmacists
James Munro, Alicia O’Cathain, Emma Knowles and Jon Nicholl
Abstract
Objectives To evaluate a pilot scheme of referrals from a nurse-led telephone helpline (NHS
Direct) to community pharmacists.
Methods A multi-method approach, including analysis of routine data from NHS Direct, postal
surveys of NHS Direct callers, analysis of anonymised transcripts of calls, a postal survey of callers
referred to pharmacists, and face-to-face interviews with NHS Direct nurses.
Setting Essex, Barking and Havering.
Key findings During the first three months of the pilot scheme, 6% (1,995/31,674) of NHS Direct
calls triaged by nurses were logged as referred to pharmacists. This built on an existing foundation of
informal referral to pharmacists of 4%. There was no measurable change in callers’ views of the
helpfulness of advice, enablement, or caller satisfaction associated with the scheme. Conditions sent
to pharmacists included skin rash, cough, sore throat, stomach pain, and vomiting and/or diarrhoea.
86% (54/63) of callers referred to pharmacists during the scheme felt the referral was very or quite
appropriate and 75% (48/64) attempted to contact a pharmacist. In general, those who did so found
the experience a positive one: 65% (31/48) spoke to the pharmacist, and 80% (28/35) of people
expressing an opinion were satisfied with the advice offered, but the lack of privacy in the pharmacy
was of some concern. Although routine data indicated high usage of the scheme, nurse referral of
callers to pharmacists declined over time. Their initial enthusiasm diminished due to concerns about
the appropriateness of guidelines, their lack of understanding of the rationale behind some refer-
rals, and the lack of feedback about the appropriateness of their referrals.
Conclusions The evaluation of the pilot scheme has generated a range of recommendations for
the wider national roll-out of the scheme, including revision of the guidelines and review of NHS
Direct nurse training for referral to pharmacy. NHS Direct and pharmacists should consider how to
strengthen the system of pharmacist feedback to NHS Direct.
Introduction
NHS Direct, the national nurse-led telephone helpline, was announced in the White
Paper ‘‘The New NHS: modern, dependable’’ in December 1997, with the aim of
providing ‘‘easier and faster advice and information for people about health, illness
and the NHS so that they are better able to care for themselves and their families’’.1 By
November 2000 the telephone service was available across England and Wales, and a
similar service for Scotland, NHS 24, became available in 2002.2
Calls to NHS Direct for advice are handled by nurses who triage each call using
computer decision support software. The primary endpoints of the triage are direct
connection to the emergency ambulance service, or advice to attend an accident and
emergency (A&E) department, contact a family doctor, or care for the problem at home.
Calls for health information rather than advice are connected to a health information
service. By 2001, the service in England was handling about five million calls per year.
Evaluation of NHS Direct3–5 has shown that it is a popular and well-used service
which callers find helpful and reassuring.6 Call rates run at about one-third the level of
out-of-hours general practice, and the pattern of use is predominantly as an out-of-hours
service, with relatively high call rates for young children and young women, and lower
than expected call rates for older adults. The great majority
of callers are seeking advice on the immediate management
of a wide range of mainly minor illnesses and injuries.
Not all callers have been happy with the service.
Important sources of dissatisfaction have included difficulties
in getting through, delay in being able to speak to a nurse,7
and the number of questions asked.3 Some evidence suggests
that the introduction of NHS Direct was associated with
halting the upward trend in demand for out-of-hours general
practice, but it has had no measurable impact on overall
demand for ambulance or accident and emergency services.8
The limited evidence available indicates that serious adverse
clinical outcomes associated with NHS Direct are rare.5
The NHS Direct pilot pharmacy scheme
In mid-1999, Essex NHS Direct, with the Essex Local
Pharmaceutical Committees, and support from the
National Pharmaceutical Association and the Royal
Pharmaceutical Society, proposed that NHS Direct
should introduce the additional endpoint of advice to
consult a pharmacist. Previous research into how and
why patients seek advice from pharmacists suggested
that such a development would be acceptable and helpful
to patients.9–12 The NHS Executive accepted this proposal
and Essex NHS Direct established a pilot scheme in which
referral to a community pharmacist was added to the
existing range of triage endpoints.
A team from the Department of Medicines Management
at Keele University was commissioned to review the com-
puter protocols then in use at Essex NHS Direct. The team
consisted of an academic pharmacist, a management con-
sultant, two general practitioners, two pharmacists, a public
health doctor and a data analyst.13 It took a working
definition that community pharmacy referral could be
valuable if the appropriate treatment was a medicine only
available from a pharmacy, significant additional advice
would be available from a pharmacist, there was low clin-
ical risk associated with referral, or the condition would
routinely be dealt with by a pharmacist. It identified a
‘‘substantial opportunity’’ for introducing the pharmacy
endpoint and, in all, 182 opportunities for referral to phar-
macy were identified in 68 of the software guidelines.13 The
decision support system was modified and local briefing
sessions, run by the local NHS Direct pharmacy project
manager and attended jointly by NHS Direct nurses and
community pharmacists, were provided to explain the pilot
scheme. The new system was introduced in March 2000.
A number of other countries — including Canada,
Australia, New Zealand and Switzerland — have estab-
lished national or sub-national telephone triage services
along the lines of NHS Direct, and informal referral to
community pharmacy to obtain medication is common.
However, we are unaware of any other system which has
established formal protocols for referring callers to com-
munity pharmacy for advice or further care.
The aim of this study was to evaluate the addition of
community pharmacy to the existing range of NHS Direct
advice, in terms of the experiences of callers and the effects
on other immediate care services.
Methods
Use of the pharmacy endpoint
Call logs generated by the decision support software were
used to study the change in referral patterns before and
after the introduction of the pilot scheme. We obtained
anonymised records of all calls received by Essex NHS
Direct during the first three months of the scheme, and for
the same three months in the previous year. The pattern of
referrals in these two time periods was compared using the
2 statistic.
Benefits to callers
Since the primary purpose of the scheme was to improve
the service to callers, we undertook a postal survey of
callers before and after the scheme. The survey included
questions on a number of potentially measurable benefits
to callers: the perceived helpfulness of advice given by
NHS Direct; feeling more able to look after themselves
or their health problem (enablement); satisfaction with
NHS Direct; and use of other services. We also asked
about the nature of the advice, the action taken, details
of any subsequent visit to a pharmacy, and basic demo-
graphic information.
The questionnaire was based on that used in a survey
of callers to first wave NHS Direct sites,6 and included the
Patient Enablement Instrument (PEI) addressing the abil-
ity of patients to deal with their problems.14 This was
originally developed to measure quality of care in general
practice, with a focus on health gain, and although it has
been validated for assessing routine general practice con-
sultations it had not been used before with NHS Direct
callers.
We had intended to select a random sample of 1,500
callers in February 2000, before the scheme began, and a
similar number afterwards, to include only callers who
could have been advised to contact a pharmacist (those
triaged using one of the 68 guidelines adapted for the
scheme). Unfortunately, at the time of the ‘‘before’’ survey
we lacked ethical approval for the study in all areas served,
and were therefore able to identify only 810 callers in the
month before the scheme began. Questionnaires were
posted to these callers by Essex NHS Direct staff in the
second week of March 2000. For the ‘‘after’’ survey, ques-
tionnaires were posted to 1,460 callers inMay, June and the
first two weeks of July 2000. Up to two reminders were sent
to non-respondents. To preserve confidentiality question-
naires were posted by NHS Direct staff, and were returned
by respondents to the research team in reply-paid envelopes.
Data were entered into SPSS, and the 2 and t-test used
to test for changes after the introduction of the scheme.
Sample size calculation
Our primary outcome was the degree to which the addi-
tion of a pharmacy endpoint to NHS Direct improved the
ability of patients to deal with their problems. For 80 per
cent power and 5 per cent significance level, 1,005 respond-
ents were needed in each time period to detect a minimum
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improvement of half a point in the PEI score (standard
deviation of 4 points). Assuming a survey response rate of
70 per cent, a sample size of 1,500 individuals was needed
in each period. Under the same assumptions, 1,150 indivi-
duals in each period would be sufficient to detect a change
from 53 per cent ‘‘very satisfied’’ with NHS Direct (as
observed in first wave sites) to 60 per cent ‘‘very satisfied’’.
Description of calls referred to the pharmacist
We planned that NHS Direct staff would identify a ran-
dom sample of 200 callers referred to pharmacists and
provide anonymised call transcripts for analysis. In prac-
tice, however, callers referred to pharmacists could not be
reliably identified from routine call logs because the
records were inaccurate, so staff had to listen to the entire
tape of each sampled call and transcribe only those which
actually mentioned pharmacy. Due to the difficulties in
locating calls, we reduced the number of transcripts
required and did not use random sampling. For each call
transcript provided, a single researcher (AOC) read the
transcript and recorded the problempresented, how the phar-
macy endpoint was introduced to the caller and the caller’s
reaction to the advice.
Users’ views of being advised to contact a
pharmacist
The questionnaire to callers included a four-page section
for completion only by callers who had been advised to
contact a pharmacist. Since we could not know in advance
what proportion of callers this might be, we planned to
survey an additional sample of 200 callers in the ‘‘after’’
period, for whom the log recorded that the caller had been
triaged to pharmacy.
NHS Direct nurses’ views of the scheme
Eight months after the introduction of the scheme, a
member of the research team (EK) visited Essex NHS
Direct. Nine nurses — the majority of those on duty at
the time — agreed to be interviewed about their experi-
ence of the scheme. Interviews took place in a quiet part of
the workplace and lasted about 15 minutes each. Notes of
each interview, made during and after the interview, were
read and reread to identify common themes.
Ethical approval
Ethical approval for the study was granted by Trent
Multi-centre Research Ethics Committee and sought
from the five local research ethics committees in Essex,
Barking and Havering. Three local committees gave
approval in time for the ‘‘before’’ survey, so only the
populations covered by these committees could be
included. This amounted to about one-third of the popu-
lation covered by Essex NHS Direct.
Results
Use of the pharmacy endpoint
In the first three months of the scheme, 6.3 per cent (1,995/
31,725) of triaged calls were logged as referred to pharma-
cists (Table 1). Compared with the same period in the
previous year, the proportion of callers directed to ‘‘rou-
tine GP’’ fell by about 5 per cent and the proportion to
‘‘self care’’ by about 4 per cent, while the proportion
directed to ‘‘immediate GP’’ rose by 3 per cent. The first
two changes might have been expected since callers dir-
ected to pharmacy would previously have been directed to
self care or routine GP care. Because Essex NHS Direct
also extended its handling of calls for local GP out-of-
hours services in May 2000, a second analysis restricted to
in-hours calls (ie, 8am to 6pm on weekdays) was also
undertaken, which showed similar changes. Although the
observed changes cannot simply be attributed to the phar-
macy scheme, since casemix and other variables may also
have changed between the two time periods examined, the
figures in Table 1 give some indication of the size of effect
that the new endpoint might have on patient flows to self
care or general practitioners.
Benefits to callers
The ‘‘before’’ survey achieved a response rate of 63 per cent
(508/801), and the ‘‘after’’ survey 60 per cent (876/1,450),
Table 1 Advice logged as given to triaged calls before and after pilot scheme.
March to May 1999 March to May 2000
Number of calls % of calls Number of calls % of calls
Pharmacist – – 1,955 6.2
A&E 1,247 9.2 3,130 9.9
GP immediate or within 4 hours 1,760 12.9 4,906 15.5
GP within 24 hours 1,958 14.4 4,492 14.2
GP routine 1,395 10.3 1,641 5.2
Self care 6,963 51.2 14,946 47.1
Other, including 999 281 2.1 655 2.1
All calls 13,604 100.0 31,725 100.0
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after removal of those returned by the Royal Mail.
There were no differences between respondents in the two
time periods in terms of the caller’s age (40.8 v 40.7 years),
age of leaving full-time education (17.2 v 17.3 years),
gender (79 per cent v 77 per cent female), whether or not
the patient paid for prescriptions (66 per cent v 63 per cent
free), when the call was made (79 per cent v 78 per cent out-
of-hours) or for whom the call was made (45 per cent v 47
per cent for the caller themselves).
Advice received
Before the scheme began, 4 per cent of callers reported
that theyhadbeen advised to contact a pharmacist (Table 2),
suggesting an existing informal practice of referral to
pharmacists. There was a statistically significant change
in advice reported by callers between the two time periods.
After the scheme began, more callers were recommended
to contact a GP urgently or a pharmacist, and fewer to
contact a GP in the next few days or to self care, than
beforehand, which is consistent with the expected substi-
tution of pharmacy for the ‘‘routine GP’’ and ‘‘self care’’
endpoints. However, the change did not remain constant
over time: the proportion of callers directed to pharmacy
decreased as the scheme progressed, from 12 per cent in
May, to 7 per cent in June and 3 per cent in July.
Helpfulness, enablement and satisfaction
Callers’ views of how helpful they found NHS Direct
advice did not change after the scheme began (Table 3).
There was weak evidence that enablement reduced over
time, but completion of the six enablement questions was
poor (14 per cent to 29 per cent of respondents did not
complete some questions in this scale). The proportion of
callers feeling much better able to cope with their illness,
or feeling much more confident about their health,
decreased so that the total enablement score fell slightly.
Nor do the results in Table 3 indicate any measurable
change in overall satisfaction: the proportion of callers
who strongly agreed that they were generally satisfied
with the service was 49 per cent before and after the
scheme (95 per cent confidence interval for change in
satisfaction 5 per cent to þ6 per cent). A statistically
significant change in views occurred in relation to the
waiting time to speak to a nurse, suggesting an improve-
ment in this aspect of the service over time, although this
is unlikely to be related to the pharmacy scheme.
Impact on other services
The actions taken by callers following their contact with
NHS Direct are shown in Table 4. The small changes in
service use evident here were not large enough to reach
statistical significance, and in particular there was no
evidence of a change in callers’ use of pharmacists before
and after the scheme.
Description of pharmacy calls
We examined anonymised transcripts of 93 calls made
once the scheme began which were both logged as referred
to a pharmacist and which included a mention of visiting a
pharmacy. Two-thirds (66/93) of these concerned children
rather than adults.
Condition and reason for calling
The conditions included skin rash (31 calls), cough (9),
sore throat (9), stomach pain (8), vomiting and/or diar-
rhoea (6), insect bite or sting (4), constipation (3), chest
pain (3), sunburn (3) and others such as hay fever, back
pain, knee pain, joint pain, threadworm, teething, ear-
ache, fever, flu and sore eyes. In 32 calls it was not clear
why the call to NHS Direct had been made. Reasons that
were clearly stated included: a desire for a diagnosis, for
example whether spots were chickenpox (20 calls); relief
from symptoms (16 calls); advice on whether a doctor was
needed (10 calls); and advice on whether a condition was
contagious (4 calls). Although all calls were triaged as calls
for nurse advice, 11 involved a question about a medica-
tion; these related mainly to issues of appropriateness,
availability and adverse effects.
Interaction between nurse and caller
In 75 calls, the nurse introduced the pharmacy referral by
suggesting the caller should ‘‘speak to a pharmacist’’, and
sometimes emphasised that it was important to speak to
Table 2 Advice reported by callers before and after pilot scheme.
Before After
Number % Number %
Contact a pharmacist 19 4 59 7
999 or A&E 87 18 154 18
GP immediately 99 20 201 24
GP in 24 hours 90 19 157 19
GP in next few days 73 15 104 12
Self care 119 24 160 19
Total 487 100 835 100
2¼ 12.7, df¼ 5, P¼ 0.026.
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the pharmacist rather than counter staff; in 12, the nurse
suggested the caller ‘‘visit a chemist’’ for a medication.
Sometimes the nurse also offered a rationale for the
advice: for example, that the pharmacist could look at a
rash (15 calls), recommend a treatment (45), or provide a
specific medication (17).
In the majority of calls the caller raised no objection to
the pharmacy referral, although in some cases practical
objections were expressed, such as already having seen a
pharmacist, already having the required medication, not
wanting medication, or being too ill to travel. In six cases,
callers expressed a preference for seeing a health profes-
sional (usually their GP) other than a pharmacist.
Users’ views of being advised to contact a pharmacist
Our ‘‘after’’ survey identified 59 callers (in 876 respond-
ents) who reported that they were advised to contact a
pharmacist. The additional survey of 200 calls logged as
referred to pharmacy identified only a further nine such
callers in 65 respondents. Of these 68 callers, 64 gave
details of the action they took, and of these fewer than
half actually spoke to a pharmacist (Figure 1).
Appropriateness of and compliance with advice
Of those callers recommended to contact a pharmacist
during the pilot scheme, 46 per cent (29/63) felt that the
Table 3 Benefits reported by callers before and after the scheme.
Before After P value
Number answering
question
% Number answering
question
%
Helpfulness
Very helpful 507 64 866 63 0.56
Enablement
Much better able to cope with life 382 12 649 9 0.40
Much better able to understand the illness/problem 424 25 713 22 0.57
Much better able to cope with illness/problem 416 26 693 19 0.02
Much better able to keep yourself healthy 368 11 610 8 0.47
Much more confident about your health 414 15 710 11 0.05
Much more able to help yourself 450 17 743 13 0.20
Mean SD Mean SD
Mean enablement score 2.98 3.31 2.62 3.09 0.10
Satisfaction*
It was difficult to get through on the telephone 462 9 805 6 0.58
I had to wait a long time to speak to the nurse 461 16 807 14 0.04
I think the nurse was understanding 485 94 835 94 0.88
I was given exactly the right amount of advice needed 474 81 825 81 0.96
I was given clear advice about when to get more help 469 86 818 88 0.76
The advice I was given worked well in practice 455 81 791 82 0.85
I felt reassured and worried less 473 81 829 81 0.93
I was generally satisfied with the service 487 90 829 90 0.95
*Satisfaction data relate to % of respondents who agreed or strongly agreed with statement.
Table 4 Contacts with other services reported by callers before and after the scheme.
Before % (n¼ 503)* After % (n¼ 852)*
999 3 3
A&E 13 16
GP urgent 26 27
GP in 24 hours 16 19
GP in next few days 13 12
Contact a pharmacist 6 6
Self care 37 33
Other 7 4
*Some respondents reported more than one contact with services.
2¼ 10.7, df¼ 7, P¼ 0.15.
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advice was very appropriate, 40 per cent that it was quite
appropriate, and 14 per cent that it was not appropriate;
75 per cent (48/64) did attempt to contact a pharmacist.
Among those who did not, five said it was inconvenient,
four said the patient’s health improved, three that the
patient’s health deteriorated, two that they went to their
GP instead, one did not agree with the advice given and
felt that the problem was more serious than NHS Direct
believed, one had the medication needed at home, and one
had already been to the pharmacist.
The pharmacy visit
Of the 48 people who did attempt to go to a pharmacy, 67
per cent (32/48) did so in under four hours; 75 per cent
(36/46) visited their usual pharmacy; 33 per cent (16/48)
got there on foot and 63 per cent (30/48) by car; and 91 per
cent (40/44) had a travel time of under 10 minutes. Two-
thirds of respondents (31/48) who went to the pharmacy
spoke to the pharmacist. When they spoke to a pharma-
cist, three-quarters (24/30) told the pharmacist that they
had been referred from NHS Direct. Almost two-thirds
(19/31) were recommended a product by the pharmacist
and a further six people were recommended a medication
by the counter staff. 71 per cent (34/48) spent some money
at the pharmacy, and 29 per cent (14/48) did not.
Outcomes
Only 39 people completed the question about the help-
fulness of advice given at the pharmacy because some felt
that the question was not applicable to them: 38 per cent
(15/39) found the advice very helpful, 56 per cent quite
helpful and 5 per cent unhelpful, which may suggest that
this advice provided ‘‘added value’’, following the original
advice from the NHS Direct nurse. Seventy-eight per cent
(31/40) acted on all of the advice, 20 per cent on some of it
and 2 per cent did not act on the advice.
Of the 48 people who went to a pharmacy, 18 (38 per
cent) subsequently went to see a GP about the same
problem and a further 4 (8 per cent) intended to see a
GP. Eight of those who went on to their GP did so on the
advice of the pharmacist. Satisfaction rates for different
aspects of the pharmacy service were reasonable, except
for privacy, which prompted dissatisfaction from about a
quarter of those who visited (Table 5). If these 48 people
had the same problem again, 31 per cent reported they
would follow the advice given by the pharmacist, 29 per
64 recommended to
contact a pharmacist
48 went to pharmacy 16 did not go to pharmacy
22 had no further referral9 advised to see GP
31 spoke to pharmacist 17 spoke to counter
assistant
Figure 1 Attrition from the pharmacy scheme.
Table 5 Satisfaction levels with different aspects of attending the pharmacy.
Very satisfied
or satisfied
Acceptable Dissatisfied
or very dissatisfied
n¼ 100%
Privacy 30% 46% 24% 37
Time with pharmacist 66% 26% 9% 35
Advice given 80% 17% 3% 35
Location of pharmacy 76% 24% 0% 37
Opening hours 65% 27% 8% 37
Counter staff 65% 35% 0% 31
Waiting time 73% 24% 3% 37
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cent would go to their GP, 15 per cent would call NHS
Direct, 6 per cent would speak to a pharmacist, 6 per cent
would manage the problem themselves, or use a combin-
ation of these things.
NHS Direct nurses’ views
At the start, all the nurses we interviewed had been enthu-
siastic about the pharmacy scheme, feeling that it could be
valuable in offering an alternative source of easily acces-
sible care to callers while reducing unnecessary visits to
GPs. Eight months on, however, most felt that their prac-
tice was ‘‘no different to what we did before’’. Many also
had specific concerns about the operation of the scheme.
In particular, they felt that some of the guidelines were
inappropriate, in that many calls for which pharmacy was
the recommended advice could be managed by self-care.
The result was that nurses overrode the system, ‘‘down-
grading’’ the advice to self-care while it was recorded as a
pharmacy endpoint in the software log. All nurses inter-
viewed had wanted to downgrade a pharmacy referral to
self-care at least once and for the majority of nurses this
had been a frequent occurrence.
Over half of the nurses felt that there was a lack of
information on the computer screen giving the rationale
behind the software recommendation to send a patient to
a pharmacist, which reinforced their belief that some
guidelines were inappropriate. The majority saw a phar-
macy referral as a way to obtain medication, rather than
advice, from the pharmacist. Additionally, some nurses
felt that there had been insufficient training on the
scheme, or wanted feedback to know whether their refer-
rals to pharmacy had been appropriate.
Discussion
Summary of findings
Taken together, the findings reported above suggest that
the pilot scheme was only partially implemented, with
initial enthusiasm for the scheme giving way to declining
use of the pharmacy endpoint over time. That this was
not reflected in the routine log data is the result of
operational policies which prevented the recording of
‘‘downgrading’’ of the advice given. Although the phar-
macy endpoint was used less than expected as time went
by — and, overall, no more often than informal advice
to consult a pharmacist had been given prior to the
scheme — when it was used, it seemed acceptable to
callers. We found no clear evidence that the scheme
either reduced or increased caller satisfaction or enable-
ment. In practice, about half of those advised to speak
with a pharmacist actually did so, and these callers were
generally satisfied with their consultation, though the
lack of privacy in the pharmacy emerged as a particular
concern for about one-quarter. About one-third of those
speaking to the pharmacist also consulted their GP
about the same condition, suggesting that the pharmacy
endpoint did not always substitute for GP care.
In general, call transcripts showed the pharmacy end-
point being used as intended. The rationale for the
referral was frequently framed simply in terms of
obtaining a medication, rather than consulting a health
professional. On the whole, callers seemed receptive to
the advice offered, except in cases where they had
already visited the pharmacy, or had a strong prior
preference for seeing their GP. We have previously
noted this as one reason for ‘‘non-compliance’’ with
NHS Direct advice.5 Of those callers advised to contact
a pharmacist, over 80 per cent thought the advice was
appropriate and 75 per cent followed it, being more
likely to follow it if they thought it appropriate, with
compliance similar to that found for advice in NHS
Direct generally.5 Among calls directed to a pharmacist,
it is notable that many (about one third) concerned
rashes, whereas only one in seven of all calls to NHS
Direct concern any skin problem.4 Nurses had a clear
and understandable rationale for the pharmacy referral
of rashes – to allow visual examination – which they
communicated to callers.
Our findings raise the question of what would have
happened had the implementation of the scheme been
complete rather than partial. The routine call data sug-
gested that, overall, the triage software may have disposed
about 6 per cent of callers to pharmacy, and had this
recommendation been accepted by nurses and acted on
by callers in all such cases, NHS Direct referrals to routine
(but not urgent) GP care may have fallen by about a half.
In practice, since neither compliance nor substitution of
care are complete, actual attendances for routine GP
appointments would have fallen to a much lesser degree.
Although these observations are speculative, they indicate
that a vigorous and sustained implementation of the phar-
macy scheme could have a small, but worthwhile, effect in
reducing the number of NHS Direct callers who go on to
consult their GP.
Why was the scheme only partially implemented? The
interviews with nurses suggested a number of relevant
contributory factors, including disagreement with some
of the guidelines, alongside a feeling that nurses should
have been involved with revising the system; unclear ration-
ale for the advice to visit a pharmacist, both in a general
sense (what does a pharmacist offer?) as well as in specific
guidelines (what can the pharmacist offer this caller?);
uncertainty over the role of pharmacists, which could
not be reduced with experience because of the lack of an
effective system of feedback from pharmacists (or audit
with pharmacists) over whether specific referrals were
indeed appropriate; and, in cases where the pharmacy
visit appeared optional, a concern on the part of nurses
to balance the potential benefits of any visit against the
degree of inconvenience or cost entailed for the patient.
Interestingly, many of these issues had been raised by
nurses before the pilot began.15 In retrospect, it may be
that the extent to which the new endpoint represented not
simply a change to computer protocols but a change to
existing clinical practice was underestimated in this pro-
ject. This recognition might have led to greater nurse
involvement at the outset.
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Strengths and weaknesses of this study
The strength of this evaluation lies in the multi-method
approach, with each sub-study addressing a specific aspect
of the scheme and the results taken together giving a
consistent and complete picture of what happened. The
partial implementation of the scheme led to particular
difficulties in the evaluation in sampling the appropriate
callers for surveys and transcripts. However, this could
not have been known in advance, nor indeed might it have
become known in the absence of the evaluation. The
Patient Enablement Instrument we used had not been
validated in the NHS Direct context and the extent of
missing data limited its value in this study. Nonetheless,
there is clearly a need to develop sensitive measures of
health gain in the context of telephone health care ser-
vices, and this instrument may yet prove useful. Rather
than developing a new tool specifically for telephone
health care research, it might be useful to formally test
the validity of this tool as part of a larger postal ques-
tionnaire. In addition, given other changes occurring at
the site during our evaluation, the use of control sites
would have strengthened confidence in our findings.
Implications for policy
Although our evaluation did not demonstrate measurable
benefits for callers, this is not proof that there were none. It
is likely that callers found using their local pharmacy more
speedy and convenient than aGP visit, and satisfaction with
the advice received was generally good. The majority of
those visiting a pharmacy bought a product, suggesting
that callers as well as nurses may have associated a visit to
the pharmacy with access to medication rather than diag-
nosis or general health advice, and this is consistent with
evidence that advice given in community pharmacies
focuses mainly on product recommendation and use.16
However, visiting the pharmacy for advice may not suit
everyone,10,17 and a quarter of those advised by NHS
Direct to visit a pharmacy did not do so. In addition, such
a referral may not be suitable for some callers or conditions,
given the evident concern over a lack of privacy.
For the NHS, reducing pressure on GP surgery time is
a major objective of the policy, and service users them-
selves regard community pharmacy as an alternative to
‘‘bothering the doctor’’.9,10 Some studies of the expansion
of the role of pharmacists have found a decrease in use of
other services, although authors of a systematic review in
this area concluded that more rigorous research was
needed.18 Such findings suggest that, if implementation
issues can be ironed out, there may be scope for pharmacy
referrals by NHS Direct to reduce demand for general
practice.
Finally, it is important to consider the workload impli-
cations for pharmacists. Other findings from this evalua-
tion indicated a willingness on the part of community
pharmacists to see a greater role for pharmacy in the
system of first contact care, in principle, although there
were reservations over how this should operate in prac-
tice.19 Pharmacists in Essex had positive views of NHS
Direct and the pilot scheme, but little experience of refer-
rals in practice. If the scheme were fully implemented, our
results suggest that pharmacists’ workload might not
greatly increase since informal referral already occurs,
some referred callers will not comply, and others will not
speak to the pharmacist even if they do visit the pharmacy.
Future implementation of the pharmacy scheme
There is a clear commitment to integrate NHS Direct with
community pharmacy nationally, along the lines piloted in
Essex. The NHS Plan promised that by 2002, ‘‘NHS
Direct will refer people, where appropriate, to help from
their local pharmacy’’ (paragraph 12.5),20 and an
increased role for community pharmacy in providing
care and advice was also confirmed in ‘‘Pharmacy in the
Future’’.21
The findings reported here suggest that modifications
to the scheme could increase the likelihood of a successful
national implementation. First, the triage guidelines for
pharmacy referral should be reviewed and revised with
NHS Direct nurses to give an explicit rationale for both
nurse and caller. Secondly, NHS Direct nurse training
should be reviewed to ensure that nurses understand the
skills and roles of community pharmacists. One possibility
is a short nurse placement in community pharmacy during
induction; training may also need to be ongoing. Thirdly,
there would be value in exploring the involvement of
pharmacists in clinical audit activities in NHS Direct.
Finally, it is important that the software in use allows the
actual advice given to the caller to be accurately logged.
Such modifications may clearly be helpful to the devel-
opment of an effective system of referral. However, the
longer term outcomes of introducing the pharmacy end-
point into NHS Direct are as yet unknown. As a fully-
implemented system is introduced nationally, it will be
important that further evaluation occurs to determine
the costs and benefits to callers and the NHS, the impact
on other services, and the safety and appropriateness of
the advice provided both by NHS Direct and by commu-
nity pharmacies.
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